DASSIE, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 2.879
AS - Asia 378
EU - Europa 321
SA - Sud America 4
AF - Africa 1
OC - Oceania 1
Totale 3.584
Nazione #
US - Stati Uniti d'America 2.876
CN - Cina 165
SG - Singapore 163
IT - Italia 139
FI - Finlandia 44
FR - Francia 30
VN - Vietnam 29
DE - Germania 27
SE - Svezia 27
GB - Regno Unito 22
IN - India 8
NL - Olanda 7
UA - Ucraina 7
IE - Irlanda 6
PL - Polonia 4
JP - Giappone 3
BR - Brasile 2
CA - Canada 2
CH - Svizzera 2
HK - Hong Kong 2
PK - Pakistan 2
TR - Turchia 2
AR - Argentina 1
AU - Australia 1
BD - Bangladesh 1
ES - Italia 1
GR - Grecia 1
LY - Libia 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
VE - Venezuela 1
Totale 3.584
Città #
Fairfield 545
Woodbridge 275
Chandler 248
Ashburn 230
Ann Arbor 188
Cambridge 188
Houston 173
Seattle 167
Wilmington 141
Singapore 131
Santa Clara 76
Boardman 71
Padova 51
Beijing 50
Princeton 48
San Diego 47
Medford 45
Des Moines 35
Dong Ket 29
Helsinki 26
New York 14
Nanjing 13
Guangzhou 10
London 10
Roxbury 9
Redwood City 8
Cagliari 7
Dublin 6
Hebei 6
Jacksonville 6
Mira 6
Shenyang 6
Kharkiv 5
Nanchang 5
Washington 5
's-Hertogenbosch 4
Bologna 4
Brendola 4
Dearborn 4
Falls Church 4
Fiuggi 4
Los Angeles 4
Pune 4
Zhengzhou 4
Amsterdam 3
Chicago 3
Fuzhou 3
Hefei 3
Jiaxing 3
Jinan 3
Lappeenranta 3
Lebanon 3
Norwalk 3
Ogden 3
Shanghai 3
Villorba 3
Agrigento 2
Bari 2
Catania 2
Changsha 2
Hong Kong 2
Istanbul 2
Karachi 2
Kunming 2
Lendinara 2
Milan 2
Phoenix 2
Scorzè 2
Taizhou 2
Venice 2
Vigevano 2
Wandsworth 2
Wroclaw 2
Americana 1
Anaheim 1
Andover 1
Belgrade 1
Bordeaux 1
Brescia 1
Brisbane 1
Caloocan City 1
Cernusco sul Naviglio 1
Charlotte 1
Chengdu 1
Ciudad Obregón 1
Council Bluffs 1
Dallas 1
Dammam 1
Dhaka 1
Distrito Federal 1
Dongguan 1
Frankfurt am Main 1
Gallarate 1
Geislingen an der Steige 1
Gliwice 1
Guidonia 1
Guiyang 1
Haikou 1
Hanover 1
Islington 1
Totale 3.013
Nome #
Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs. 190
Paradoxical GH increase during OGTT is associated to first-generation somatostatin analogs responsiveness in acromegaly 170
Insulin-like factor 3 plasma levels in acromegaly before and after somatostatin analog treatment. 134
Coronary microvascular dysfunction may be related to IGF-1 in acromegalic patients and can be restored by therapy 131
Ovarian tumors secreting insulin. 119
Ambulatory arterial stiffness indexes in acromegaly 116
A very rare case of nonfunctioning pituitary adenoma incidentally disclosed at 18F-FDG PET/CT. 113
Intracranial internal carotid artery changes in acromegaly: a quantitative magnetic resonance angiography study. 112
Coronary microvascular function in patients with Cushing's syndrome. 108
Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues 103
Persistent reduction of circulating myeloid calcifying cells in acromegaly. Relevance to the bone-vascular axis 102
Sleep disorders and cognitive dysfunction in acromegaly 98
Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity 98
Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing's syndrome. 95
Radiotherapy in acromegaly: Long-term brain parenchymal and vascular magnetic resonance changes 92
Ambulatory Arterial Stiffness Indexes in Cushing’s Syndrome 90
Obstructive Sleep Apnea in Acromegaly and the Effect of Treatment: A Systematic Review and Meta-Analysis 86
Left ventricular geometry and 24-h blood pressure profile in Cushing’s syndrome 78
Preclinical markers of atherosclerosis in acromegaly: a systematic review and meta-analysis 75
Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs 73
Cutis verticis gyrata associated with acromegaly 70
Guidelines versus real life practice: the case of colonoscopy in acromegaly 69
The Endothelium in Acromegaly 68
Neurocognitive assessment and DNA sequencing expand the phenotype and genotype spectrum of Alström syndrome 68
null 67
"Exploring the role of growth hormone antagonist on adipocytes" 66
Acromegaly and ultrasound: how, when and why? 65
Ovarian 25OH-vitamin D production in young women affected by polycystic ovary syndrome 61
Pharmacological approaches to controlling cardiometabolic risk in women with pcos 60
Cochlear Implants in Alström Syndrome 59
Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity: an observational study 56
Defining renal phenotype in Alström syndrome 54
Electrophysiological features in acromegaly: re-thinking the arrhythmic risk? 52
CARDIO-CEREBRO-VASCULAR RISK ASSESSMENT AND COMPLICATIONS IN ACROMEGALY 50
In vitro chronic glycation induces AGEs accumulation reducing insulin stimulated glucose uptake and increasing GLP1R in adipocytes 48
Consensus clinical management guidelines for Alström syndrome 46
Liver Fibrosis and Steatosis in Alstrom Syndrome: A Genetic Model for Metabolic Syndrome 46
Practical Considerations for the Management of Cushing's Disease and COVID-19: A Case Report 42
En early rare MEN 1 Phenotype. 41
Collaboration for rare diabetes: understanding new treatment options for Wolfram syndrome 36
Dome-and-dart T Waves and Hyperthyroidism - A Case Report 34
Alström syndrome: an ultra-rare monogenic disorder as a model for insulin resistance, type 2 diabetes mellitus and obesity 33
Paternal uniparental isodisomy of chromosome 2 in a patient with CNGA3-associated autosomal recessive achromatopsia 26
Do Androgenic Pattern, Insulin State and Growth Hormone Affect Cardiorespiratory Fitness and Strength in Young Women with PCOS? 25
Ovarian tumors secreting insulin 25
The role of the dentist and orthodontist in recognizing oro-facial manifestations of acromegaly: a questionnaire-based study 23
Questionnaire and tools: clinical powerful instrument in acromegaly diagnosis and management 22
GLOBAL PSYCHOLOGICAL ASSESSMENT WITH EVALUATION OF LIFE AND SLEEP QUALITY, SEXUAL AND COGNITIVE FUNCTION IN A LARGE NUMBER OF PATIENTS WITH ACROMEGALY: : A cross-sectional study 22
Hematopoietic stem cells and metabolic deterioration in Alström syndrome, a rare genetic model of the metabolic syndrome 22
Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY 17
GH/IGF-1 axis in a large cohort of ß-thalassemia major adult patients: a cross-sectional study 17
Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life 13
SGLT2 Inhibitors in the Management of Type 1 Diabetes (T1D): An Update on Current Evidence and Recommendations 12
Oral Manifestations and Maxillo-Facial Features in the Acromegalic Patient: A Literature Review 12
Skin manifestations in rare types of diabetes and other endocrine conditions 10
Case Report:Pregnancy and birth in a mild phenotype of Alström syndrome 10
Real-life data of Pasireotide LAR in acromegaly: a long-term follow-up 7
The physiological sonographic features of the ovary in healthy subjects: a joint systematic review and meta-analysis by the Italian Society of Gynecology and Obstetrics (SIGO) and the Italian Society of Endocrinology (SIE) 7
Disease control of acromegaly does not prevent excess mortality in the long term: results of a nationwide survey in Italy 7
The Italian registry for patients with Prader-Willi syndrome 4
Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysis 4
Totale 3.659
Categoria #
all - tutte 16.570
article - articoli 16.138
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.708


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020550 0 0 0 0 67 47 74 77 82 83 63 57
2020/2021628 60 27 30 47 31 19 42 41 60 87 35 149
2021/2022640 35 80 60 35 30 35 33 57 53 29 48 145
2022/2023494 99 57 11 49 76 69 6 39 49 4 26 9
2023/2024319 9 41 55 28 24 40 11 15 16 13 26 41
2024/2025406 4 139 55 57 151 0 0 0 0 0 0 0
Totale 3.659